|
000
| 01251nam##2200241za#4500 |
|---|
| 001 | 9.700315 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20210625000800 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 150407|2015||||xxc|||||o f|0| 0 eng|d |
|---|
| 020 | |a978-1-100-25659-7 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aEn14-212/2015E-PDF |
|---|
| 110 | 1 |aCanada. |bEnvironment Canada. |
|---|
| 245 | 10|aScreening assessment - 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- (Doxorubicin) / |h[electronic resource]|c[co-published with] Health Canada. |
|---|
| 260 | |aOttawa - Ontario : |bEnvironment Canada |cFebruary 2015. |
|---|
| 300 | |a54p.|bfigs., references, tables |
|---|
| 500 | |a"Chemical Abstracts Service Registry Number 23214-92-8" |
|---|
| 590 | |a15-09|b2015-02-27 |
|---|
| 690 | 07|aChemicals|2gcpds |
|---|
| 775 | 08|tÉvaluation préalable - (8S,10S)-10-(4-amino-5-hydroxy-6-méthyl-tétrahydro-2H-pyran-2-yloxy)-6,8,11-trihydroxy-8-(2-hydroxyacétyl)-1-méthoxy-7,8,9,10-tétrahydrotétracène-5,12-dione (Doxorubicine) / |w(CaOODSP)9.644211 |
|---|
| 856 | 40|ahttp://publications.gc.ca|qPDF|s372 KB|uhttps://publications.gc.ca/collections/collection_2015/ec/En14-212-2015-eng.pdf |
|---|